- ATyr Pharma (NASDAQ:LIFE) agrees to sell ~9.2M shares at $0.541 per share yielding $5M to The Federated Kaufmann Small Cap Fund and existing shareholder Paul Schimmel, Ph.D., in a registered direct offering.
- Proceeds will be used to advance clinical development of ATYR1923, and for other general corporate purposes.
- Closing date is April 12.
- Shares are down 4% premarket.
ATyr Pharma secures $5M capital raise; shares down 4% premarket
Recommended For You
More Trending News
About LIFE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LIFE | - | - |
aTyr Pharma, Inc. |